Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.4 EUR | +1.41% |
|
-2.47% | -7.07% |
25/06 | US CDC alerts healthcare providers of increase in dengue cases | RE |
25/06 | Takeda's Cancer Drug Gets European Commission Approval | MT |
Evolution of the average Target Price on Takeda Pharmaceutical Company Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Takeda Pharmaceutical Company Limited
Jefferies & Co. | |
TD Cowen | |
BofA Securities | |
Cowen | |
Morgan Stanley |
EPS Revisions
- Stock Market
- Equities
- 4502 Stock
- TKD Stock
- Consensus Takeda Pharmaceutical Company Limited